Cargando…

Retracted: FOXD1 Regulates the Sensitivity of Cetuximab by Regulating the Expression of EGFR in Head and Neck Squamous Cell Cancer

Detalles Bibliográficos
Autor principal: Healthcare Engineering, Journal of
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10396555/
https://www.ncbi.nlm.nih.gov/pubmed/37539336
http://dx.doi.org/10.1155/2023/9818213
_version_ 1785083783819558912
author Healthcare Engineering, Journal of
author_facet Healthcare Engineering, Journal of
author_sort Healthcare Engineering, Journal of
collection PubMed
description
format Online
Article
Text
id pubmed-10396555
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-103965552023-08-03 Retracted: FOXD1 Regulates the Sensitivity of Cetuximab by Regulating the Expression of EGFR in Head and Neck Squamous Cell Cancer Healthcare Engineering, Journal of J Healthc Eng Retraction Hindawi 2023-07-26 /pmc/articles/PMC10396555/ /pubmed/37539336 http://dx.doi.org/10.1155/2023/9818213 Text en Copyright © 2023 Journal of Healthcare Engineering. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Healthcare Engineering, Journal of
Retracted: FOXD1 Regulates the Sensitivity of Cetuximab by Regulating the Expression of EGFR in Head and Neck Squamous Cell Cancer
title Retracted: FOXD1 Regulates the Sensitivity of Cetuximab by Regulating the Expression of EGFR in Head and Neck Squamous Cell Cancer
title_full Retracted: FOXD1 Regulates the Sensitivity of Cetuximab by Regulating the Expression of EGFR in Head and Neck Squamous Cell Cancer
title_fullStr Retracted: FOXD1 Regulates the Sensitivity of Cetuximab by Regulating the Expression of EGFR in Head and Neck Squamous Cell Cancer
title_full_unstemmed Retracted: FOXD1 Regulates the Sensitivity of Cetuximab by Regulating the Expression of EGFR in Head and Neck Squamous Cell Cancer
title_short Retracted: FOXD1 Regulates the Sensitivity of Cetuximab by Regulating the Expression of EGFR in Head and Neck Squamous Cell Cancer
title_sort retracted: foxd1 regulates the sensitivity of cetuximab by regulating the expression of egfr in head and neck squamous cell cancer
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10396555/
https://www.ncbi.nlm.nih.gov/pubmed/37539336
http://dx.doi.org/10.1155/2023/9818213
work_keys_str_mv AT healthcareengineeringjournalof retractedfoxd1regulatesthesensitivityofcetuximabbyregulatingtheexpressionofegfrinheadandnecksquamouscellcancer